Stephanie Heintz, M.P.H

Stephanie Heintz, M.P.H

Stephanie Heintz is the Executive Director, Head of Human Resources at Neogene Therapeutics. Before joining Neogene, Heintz served as Senior Director of Human Resources at AnaptysBio, where she was responsible for the development and execution of human resource strategy in support of the overall business plan, specifically in the areas of talent acquisition, organizational and […]

Han Lee, Ph.D.

Han Lee

Han Lee, Ph.D., MBA, is the Chief Financial Officer at Neogene Therapeutics. Before joining Neogene, Dr. Lee served as Chief Financial Officer of Arcellx where he oversaw the company’s financial operations, corporate financings, and was instrumental in its growth from pre-clinical to clinical. Previously, Dr. Lee worked in the Corporate Development and Ventures group at […]

David Lund, Ph.D.

David Lund

David Lund, Ph.D., is the Vice President, Intellectual Property at Neogene Therapeutics. Before coming to Neogene, Dr. Lund served most recently as Senior IP Counsel at Agenus, where his responsibilities included managing IP issues for Agenus’ affiliate AgenTus in addition to early stage and near-commercial antibody programs of Agenus. Prior to that, Dr. Lund was […]

Kanti Thirumoorthy, Ph.D.

Kanti Thirumoorthy

Dr. Thirumoorthy is the Senior Vice President of Technical Operations at Neogene Therapeutics. She has 19 years of experience in the pharmaceutical industry, including in cell therapies, with expertise in technical operations, chemistry, Manufacturing and Control (CMC), quality control and quality assurance/compliance. Before joining Neogene, she spent six years at Kite Pharma, where she most […]

Arianne Perez Garcia, Ph.D.

Arianne Perez

Dr. Perez Garcia is the Vice President of Translational Sciences at Neogene Therapeutics. She has more than 16 years of combined academic and biopharma industry experience in cancer immunology and immunotherapy research supporting preclinical projects for engineered T cell therapies in oncology. Before joining Neogene, she spent nearly seven years at Kite Pharma, where she […]

Mauro P. Avanzi, M.D., Ph.D.

Mauro Avanzi

Dr. Avanzi, an expert in immuno-oncology and adoptive T cell therapy, joined Neogene Therapeutics as Vice President, Clinical Development. Prior to joining Neogene, Dr. Avanzi held a number of positions of increasing responsibility at Kite Pharma, serving most recently as Executive Medical Director, where he supported multiple clinical programs through all stages of development. Dr. […]

Brent Pfeiffenberger, Pharm.D., MBA

Brent Pfeiffenberger

Brent Pfeiffenberger, Pharm.D., MBA, is the Chief Operating Officer at Neogene Therapeutics. At Neogene, Dr. Pfeiffenberger oversees the company’s global business operations. Before joining Neogene, Dr. Pfeiffenberger most recently served as senior vice president, U.S. Oncology, at Bristol Myers Squibb where he oversaw an extensive oncology portfolio. Prior to that, Dr. Pfeiffenberger held several critical […]

Franz B. Humer, Ph.D.

Franz B. Humer, Ph.D.

Franz B. Humer, Ph.D. M.B.A., is the Executive Chairman of the Board of Directors at Neogene Therapeutics. Dr. Humer joined Hoffmann-La Roche in 1995 as a member of its Board and the head of its pharmaceuticals division, progressing to become Chairman and CEO in 2001, and between 2008 and 2014 the Chairman of Roche Holding […]

Ton N.M. Schumacher, Ph.D.

Ton Schumacher

Ton N.M. Schumacher, Ph.D., is a Co-Founder of Neogene Therapeutics and Principal Investigator at The Netherlands Cancer Institute, Oncode Institute member, and Professor of Immunotechnology at Leiden University Medical Center. Dr. Schumacher previously co-founded AIMM Therapeutics, Neon Therapeutics and T Cell Factory and served as Chief Scientific Officer of Kite Pharma EU. In addition, Dr. […]

Gavin M. Bendle, Ph.D.

Dr. Gavin M. Bendle is the Senior Vice President of Research and Development at Neogene Therapeutics. He has been actively engaged in the field of adoptive T cell therapy of cancer for over 17 years and has co-authored numerous publications on this subject. Before joining Neogene, Dr. Bendle was a Senior Director of Cell Therapy […]